Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China
· Delayed Price · Currency is CNY 19.03
+0.48 (2.59%)
Apr 1, 2025, 2:45 PM CST
SHA:601607 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 4,553 | 3,768 | 5,617 | 5,093 | 4,496 | Upgrade
|
| Depreciation & Amortization | 2,243 | 2,187 | 2,222 | 2,140 | 2,138 | Upgrade
|
| Other Amortization | 367.73 | 192.33 | 195.59 | 186.89 | 160.66 | Upgrade
|
| Loss (Gain) From Sale of Assets | -187.97 | -92.48 | -1,439 | -58.29 | -52.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 448.52 | 70.65 | 322.39 | 88.98 | 502.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | -721.89 | -383.74 | 30.06 | 204.41 | -126.5 | Upgrade
|
| Provision & Write-off of Bad Debts | 255.56 | 254.34 | 276.33 | -54.29 | -84.83 | Upgrade
|
| Other Operating Activities | 3,215 | 3,579 | 2,196 | 860.27 | 1,824 | Upgrade
|
| Change in Accounts Receivable | -4,041 | -6,432 | -10,081 | -6,156 | -4,072 | Upgrade
|
| Change in Inventory | -2,298 | -2,304 | -7,112 | -3,201 | 932.6 | Upgrade
|
| Change in Accounts Payable | 2,103 | 4,586 | 12,645 | 5,793 | 1,360 | Upgrade
|
| Operating Cash Flow | 5,827 | 5,232 | 4,743 | 5,061 | 6,845 | Upgrade
|
| Operating Cash Flow Growth | 11.39% | 10.29% | -6.28% | -26.05% | 13.66% | Upgrade
|
| Capital Expenditures | -2,401 | -2,971 | -2,685 | -4,119 | -3,010 | Upgrade
|
| Sale of Property, Plant & Equipment | 244.66 | 179.15 | 160.34 | 190.9 | 383.86 | Upgrade
|
| Cash Acquisitions | -85.29 | -357.08 | -84.33 | -1,153 | 56.2 | Upgrade
|
| Divestitures | - | 0.5 | 106.8 | -1,454 | 110.13 | Upgrade
|
| Investment in Securities | 1,338 | -436.23 | -10,486 | -86.68 | -808.25 | Upgrade
|
| Other Investing Activities | 1,320 | 1,092 | 514.75 | 606.31 | 1,562 | Upgrade
|
| Investing Cash Flow | 415.98 | -2,492 | -12,473 | -6,016 | -1,706 | Upgrade
|
| Short-Term Debt Issued | 137.37 | 163.6 | 363.04 | 29.26 | 174.66 | Upgrade
|
| Long-Term Debt Issued | 73,925 | 79,193 | 63,644 | 56,547 | 49,265 | Upgrade
|
| Total Debt Issued | 74,063 | 79,357 | 64,008 | 56,576 | 49,440 | Upgrade
|
| Short-Term Debt Repaid | -669.24 | -1,325 | -394.85 | -329.58 | -267.97 | Upgrade
|
| Long-Term Debt Repaid | -70,845 | -73,120 | -60,557 | -53,003 | -48,306 | Upgrade
|
| Total Debt Repaid | -71,514 | -74,445 | -60,952 | -53,333 | -48,574 | Upgrade
|
| Net Debt Issued (Repaid) | 2,549 | 4,912 | 3,055 | 3,243 | 865.24 | Upgrade
|
| Issuance of Common Stock | 86.2 | 106.42 | 13,982 | - | - | Upgrade
|
| Common Dividends Paid | -3,604 | -3,981 | -3,094 | -2,676 | -2,418 | Upgrade
|
| Other Financing Activities | -895.25 | -805.36 | -1,805 | 998.55 | 291.92 | Upgrade
|
| Financing Cash Flow | -1,864 | 231.85 | 12,139 | 1,566 | -1,261 | Upgrade
|
| Foreign Exchange Rate Adjustments | 2.16 | -5.58 | -12.44 | -50.32 | -17.63 | Upgrade
|
| Net Cash Flow | 4,381 | 2,966 | 4,396 | 561.06 | 3,860 | Upgrade
|
| Free Cash Flow | 3,426 | 2,261 | 2,058 | 942.55 | 3,835 | Upgrade
|
| Free Cash Flow Growth | 51.55% | 9.83% | 118.40% | -75.42% | 17.30% | Upgrade
|
| Free Cash Flow Margin | 1.25% | 0.87% | 0.89% | 0.44% | 2.00% | Upgrade
|
| Free Cash Flow Per Share | 0.93 | 0.61 | 0.59 | 0.33 | 1.35 | Upgrade
|
| Cash Income Tax Paid | 7,170 | 7,384 | 7,599 | 6,239 | 5,849 | Upgrade
|
| Levered Free Cash Flow | 2,009 | 16 | -595.85 | -1,374 | 1,482 | Upgrade
|
| Unlevered Free Cash Flow | 3,170 | 1,194 | 459.95 | -425.52 | 2,365 | Upgrade
|
| Change in Net Working Capital | 2,509 | 4,034 | 4,397 | 3,331 | 1,510 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.